Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

"was this included in last years proxy as well or is it new"

Yes, it was.

Share
New Message
Please login to post a reply